Cite
HARVARD Citation
Cui, W. et al. (2021). Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming. Clinical and translational medicine. 11 (7), p. n/a. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cui, W. et al. (2021). Screening‐based identification of xanthone as a novel NLRP3 inflammasome inhibitor via metabolic reprogramming. Clinical and translational medicine. 11 (7), p. n/a. [Online].